补体因子B的AMD相关风险变体功能评估
研究比较了补体因子B(CFB)的32R、32W和32Q三种人类变体在小鼠胎儿跖骨外植体模型中对血管生成的影响。结果显示CFBR32的促血管生成活性显著高于CFBQ32或CFBW32,且变体间巨噬细胞表型存在差异。结论认为三种变体的生物学活性与其AMD风险关联一致,为这些变体在新生血管性AMD发病机制中的作用提供了功能证据。
要点
- CFBR32在小鼠跖骨模型中促血管生成活性显著高于CFBQ32和CFBW32。
- CFB变体间巨噬细胞表型存在差异,可能贡献其生物学活性。
- 变体生物学活性与新生血管性AMD风险关联一致。
核心结论
- CFBR32、CFBW32和CFBQ32的生物学活性与其AMD风险关联一致。
- 这些变体在血管生成中的作用可能与非新生血管性AMD的发病机制相关。
研究设计与样本
- 研究将人类CFB的32R、32W和32Q变体在人胚胎肾293T细胞中表达并从培养上清中纯化。
- 采用小鼠胎儿跖骨外植体模型,将跖骨在三种CFB变体存在下培养,免疫染色后测量血管生成。
- 使用ELISA定量跖骨培养物中C3和VEGF蛋白水平,并用定量PCR测量Cfb、C3和Vegf表达。
主要发现
- 三种CFB变体在小鼠跖骨实验中生物活性不同,CFBR32的血管生成活性显著高于CFBQ32或CFBW32,后两者大致相似。
- 观察到两种变体间巨噬细胞表型存在差异,可能贡献其在该实验模型中的活性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The 32W and 32Q variants of complement factor B (CFB) are associated with reduced risk of developing neovascular age-related macular degeneration (AMD) compared with the common 32R allele. The objective of this study was to determine if the most protective R32Q variant affects the neovascular process in a manner consistent with the reported reduced disease association. METHODS: The 32R, 32W, and 32Q human CFB variants were expressed in human embryonic kidney 293T cells and purified from culture supernatant. The ex vivo mouse fetal metatarsal explant model was used to investigate the effect of these three human CFB variants on angiogenesis. Metatarsal bones were isolated from mouse embryos and cultured in the presence of the three CFB variants, and angiogenesis was measured following immunostaining of fixed samples. ELISAs were used to quantify C3 and VEGF protein levels in metatarsal culture and quantitative PCR to measure Cfb, C3, and Vegf expression. RESULTS: We show here that the three CFB variants have different biological activities in the mouse metatarsal assay, with CFBR32 exhibiting significantly greater angiogenic activity than CFBQ32 or CFBW32, which were broadly similar. We also observed differences in macrophage phenotype with these two variants that may contribute to their activities in this experimental model. CONCLUSIONS: We have demonstrated that the biological activities of CFBR32, CFBW32, and CFBQ32 are consistent with their AMD risk association, and we provide functional evidence of roles for these variants in angiogenesis that may be relevant to the pathogenesis of the neovascular form of AMD.
引用
- Pilotti C, Greenwood J, Moss SE, et al. Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B. Invest Ophthalmol Vis Sci. 2020. PMID: 32407521. doi:10.1167/iovs.61.5.19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。